velopment, manufacture, marketing and sale of pharmaceutical products, including our ability and the ability of companies with whom we do business to obtain necessary regulatory approvals; our ability to manage the growth of our business by successfully identifying, developing, acquiring or licensing new products at favorable prices and marketing such new products; our ability to obtain regulatory approval and customer acceptance of new products, and continued customer acceptance of our existing products; changes in tax laws or interpretations that could increase our consolidated tax liabilities; the other risks identified in our Annual Report on Form 10-K for the year ended December 31, 2007; and other risks detailed from time-to-time in our public filings, financial statements and other investor communications.
We caution you that the foregoing list of important factors is not exclusive. In addition, in light of these risks and uncertainties, the matters referred to in our forward-looking statements may not occur. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as may be required by law.
'/>"/>SOURCE Warner Chilcott Limited Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco2.
Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction3.
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 20074.
Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference5.
Warner Chilcott to Present at the 2008 Wachovia Healthcare Conference6.
Warner Chilcott Announces 2008 Financial Guidance7.
Pinstripe Healthcare Group Adds Veteran HR Executive Warner as Client Services Director8.
Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner9.
CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecoms IP VPN10.
LodgeNet Appoints John E. Haire, Former Time Warner Executive, to Board of Directors11.
Warner Chilcott Announces Settlement of Securities Litigation